scorecardresearch
Tuesday, July 22, 2025
TopicPradhan Mantri Bharatiya Janaushadhi Pariyojana

Topic: Pradhan Mantri Bharatiya Janaushadhi Pariyojana

Jan Aushadhi’s mega success gave Mandaviya’s CV a boost before promotion to health minister

During his stint as MoS for chemicals & fertilizers, Mansukh Mandaviya oversaw revenue earnings from affordable generic drugs go up 5,500%, to Rs 665 crore from Rs 12 crore in 5 years.

Govt orders immediate audit after suspicion of scam in medicines-for-all scheme

An internal audit found many irregularities in the implementation of the PMBJP, and minister Mandaviya says he’s ordered another one to probe them.

Affordable drugs scheme in crisis: 3 CEOs quit in 3 years, no replacement found since

BPPI, the bureau that runs the Pradhan Mantri Bharatiya Janaushadhi Pariyojana, has been looking for a CEO since November last year.

On Camera

Bihar mimics 19th-century American South. Citizenship is now weaponised to exclude voters

Disenfranchisement by institutional fiat is profoundly undemocratic. The effect of the ECI's new documentary process in Bihar will tilt the scales in favour of the BJP.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

Not just AK-203, India & Russia to jointly manufacture AK-19 and PPK-20 for domestic use and export 

India-Russia JV is also racing to deliver 7,000 more AK-203 assault rifles by 15 Aug. These are currently being made with 50% indigenisation and this will surge to 100% by 31 December.

Strategic partner one day, tactical nightmare the next: India’s learning Trumplomacy the hard way

Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.